Editor - Constance Albarracin | University of Texas MD Anderson | 5505
ISSN: 2161-0681

Journal of Clinical & Experimental Pathology
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Constance Albarracin

Constance Albarracin
Constance Albarracin
Associate Professor
University of Texas MD Anderson Cancer Centre
University of Texas MD Anderson Cancer Center


Dr. Constance Albarracin, MD, Ph.D. is a surgical pathologist and tenured professor at MD Anderson Cancer Center, Houston. She completed her pathology residency training at the University of Chicago Medical School, her MD degree from the University of Santo Tomas in the Philippines and her PhD degree in Physiology at the University of Illinois in Chicago.  Dr. Albarracin did her postdoctoral fellowship at the Brigham and Women\s Hospital, Harvard Medical School. She subspecialized in Breast and Gynecologic Pathology at the Beth Israel Hospital in Boston and at MD Anderson Cancer Center. Currently an Associate Professor at University of Texas M.D. Anderson, she has developed her research with BRCA-associated cancers and the role of microRNAs in breast and uterine cancer progression.

Research Interest

BRCA associated cancers, breast cancer and uterine cancer progression.



Global Speakers in the subject

Global Experts in the subject


Evolving Role of Ki67 as a Predictive and Prognostic Marker in Breast Cancer

Constance Albarracin and Sagar Dhamn
Editorial: J Clin Exp Pathol 2014, 4: e119
DOI: 10.4172/2161-0681.1000e119